Evaluation of the solitary pulmonary nodule by positron emission tomography imaging

European Respiratory Journal

Volumn 9, Issue 3, 1996, Pages 410-414

  Bury, T ^a   Dowlati, A ^a   Paulus, P ^a   Corhay, J L ^a   Benoit, T ^a   Kayembe, J M ^a   Limet, R ^a   Rigo, P ^a   Radermecker, M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

fluorodeoxyglucose; positron emission tomography; pulmonary nodule

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; COIN LESION, PULMONARY; CONFIDENCE INTERVALS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029964011     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09030410     Document Type: Article

References (30)

1. Swensen SJ, Jett JR, Payne WS, Viggiano RW, Pairolero PC, Trastek VF. An integrated approach to evaluation of the solitary pulmonary nodule. Mayo Clin Proc 1990; 65: 173-186.
2. Walske BR. The solitary pulmonary nodule: a review of 217 cases. Dis Chest 1966; 49: 302-304.
3. Khouri NF, Meziane MA, Zerhouni EA, Fishman EK, Siegelman SS. The solitary pulmonary nodule, assessment, diagnosis and management. Chest 1987; 91: 128-133.
4. Lillington GA. Pulmonary nodules: solitary and multiple. Clin Chest Med 1982; 3: 361-367.
5. Zerhouni EA, Stitik FP, Siegelman SS, et al. CT of the pulmonary nodules: a co-operative study. Radiology 1986; 160: 319-327.
6. Hatamaka M. Transport of sugars in tumor cell membranes. Biochem Biophys Acta 1974; 355: 74-104.
7. Flier JS, Mueckleer MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras and sarc oncogenes. Science 1987; 23: 1492-1495.
8. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32: 623-648.
9. Patz E, Lowe V, Hoffman J, Paine S, Harris L, Goodman P. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 1994; 191: 379-382.
10. Lowe VJ, Hoffman JM, Delong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35: 1771-1776.
11. Diem K. Tables scientifiques. Documenta Geigy. 6ème édition. J.R. Geigy SA, ed. Basic, 1963; pp. 85-103.
12. Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1972; 64: 413-421.
13. Midthun DE, Swensen SJ, Jett JR. Clinical strategies of solitary pulmonary nodule. Ann Rev Med 1992; 43: 195-208.
14. Zeihouni EA, Khouri NF, Leo FP, Fishman EK, Braverman RM. Solitary pulmonary nodules: CT assessment. Radiology 1986; 160: 307-312.
15. Mack MJ, Hazelrigg SR, Landreneau RJ, Acuff TE. Thoracoscopy for the diagnosis of the indeterminate solitary pulmonary nodule. Ann Thorac Surg 1993; 56: 825-832.
16. Hoh C, Hawkins R, Glaspy J, et al. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr 1993; 17: 582-589.
17. Knopp MV, Strauss LG, Haberkom U, et al. PET for the diagnostic work up in thoracic oncology. Eur J Nucl Med 1990; 16: 560 (Abstract).
18. Minn H, Joensuu H, Ahonen A, Klesni P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 1988; 61: 1776-1781.
19. Alavi JB, Alavi A, Chawluk J. Positron emission tomography in patients with glioma: a prediction of prognosis. Cancer 1988; 62: 1074-1078.
20. Lewis P, Griffin S, Marsden P, et al. Whole-body 18-F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet 1994; 344: 1265-1266.
21. Gupta N, Franck A, Dewan N, et al. Solitary nodules: detection of malignancy with PET with 2-[18F]-fluoro-2-deoxy-D-glucose. Radiology 1992; 184: 441-444.
22. Whal R, Quint L, Greenough R, Meyer C, White R, Orringer M. Staging of mediastinal non-small cell lung cancer with FDG PET, CT and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-377.
23. Collins VP, Loeffler RK, Tivey H. Observations on growth rates of human tumors. Am J Roentgenol Rod Ther 1956; 76: 988-1000.
24. Kerr KM, Lamb D. Actual growth rate and tumour cell proliferation in human pulmonary neoplasms. Br J Cancer 1984; 50: 343-349.
25. Brudin L, Valind S, Rhodes C, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994; 21: 297-305.
26. Pantin C, Valind S, Sweatman M, et al. Measures of the inflammatory response in cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1988; 138: 1234-1241.
27. Haslett C, Clark R, Jones H, Krausz T, Rhodes C. Neutrophil metabolic activity in localized pulmonary inflammation measured non-invasively by positron emission tomography (PET). Physiologist 1989; 32: 210-213.
28. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography a prospective study. J Nucl Med 1990; 31: 1927-1933.
29. Dewan N, Gupta N, Redepenning L, Phallen J, Frick M. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Chest 1993; 104: 997-1002.
30. Patz E, Lowe V, Hoffman J, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188: 487-490.